ABBY HERGET: Open Payments
NPI 1447666466 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 34 payments from 19 companies in 2025. Trend: 2023 $575 · 2024 $695 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $110 |
| Lilly USA, LLC | 4 | $82 |
| Madrigal Pharmaceuticals | 2 | $81 |
| Novo Nordisk Inc | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| PFIZER INC. | 2 | $50 |
| ALK-Abello, Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $36 |
| Organon LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: VRAYLAR, REZDIFFRA, MOUNJARO, CAPLYTA, NEFFY, REXULTI, NEXPLANON, Wegovy.
Industry payments across MA — which companies pay providers there.
